Treatment of Hepatitis C Infection

Self-StudyTreatment of Hepatitis C Infection

Treatment of Hepatitis C
Sign In or Register to get started

Lesson 4. Treatment of HCV in Persons with Cirrhosis

Treatment of Hepatitis C

You are just a few steps away from free CE credits!

1

Sign in or Register

A free account is required.

2

Study the Material

An entire Cc section, or just a few topics at a time.

3

Take the CE Quiz

5 questions covering the topics in each Cc section.

4

Claim CE Credit

Free CNE and Free CME available!

loading

New Users

Create a free account to get started.

Required for CE

Returning Users

Forgot password?

Treatment of HCV in Persons with Cirrhosis Overview

About this Lesson

Last Updated: October 5th, 2023

CNE/CME Continuing Education

This lesson qualifies for:
  • 1 CME AMA PRA Category 1 Credit™, or
  • 1 CNE contact hour and 1 CE contact hour (qualifies for pharmacology CE for advanced practice nurses)

CNE and CME Origination: July 1st, 2015
CNE and CME Review: November 1st, 2023
CNE and CME Expiration: October 31st, 2026 (4th Edition)

View CE Notices

Steps to Acquire CE for this Lesson:

1

Quiz

Score 80%+
2

Give Feedback

Complete survey
3

Print CE Certificate

Obtain proof of CE

4th Edition

This is a substantial revision of the original Lesson. The previous edition was titled Treatment of HCV in Persons with Cirrhosis and available until October 31st, 2023.

Learning Objectives

  • Distinguish persons with compensated cirrhosis from those with decompensated cirrhosis
  • Summarize the impact of treating HCV in persons with cirrhosis
  • Discuss major studies involving regimens with pangenotypic activity used to treat HCV in persons with compensated cirrhosis
  • Provide appropriate HCV treatment options for persons with compensated cirrhosis
  • List approaches to treatment of HCV in persons with decompensated cirrhosis

Lesson Contributors

Authors

H. Nina Kim, MD, MSc
H. Nina Kim, MD, MSc
Professor of Medicine
Division of Allergy & Infectious Diseases
University of Washington
Disclosures:
None
Paula P. Cox-North, PhD, APRN
Paula P. Cox-North, PhD, MN, ARNP
Hepatitis and Liver Clinic
Harborview Medical Center
University of Washington
Disclosures:
Speaking Fee: Gilead Sciences
The relevant financial relationship was mitigated.

Reviewers

Maria A. Corcorran, MD, MPH
Maria A. Corcorran, MD, MPH
Assistant Professor
Division of Allergy & Infectious Diseases
University of Washington
Disclosures:
None
David H. Spach, MD
David H. Spach, MD
Professor of Medicine
Division of Allergy & Infectious Diseases
University of Washington
Disclosures:
None

Lesson Plan

1Topic 1 Background

2Topic 2 Impact of Treating HCV in Persons with Cirrhosis

3Topic 3 Treating HCV in Persons with Compensated Cirrhosis

4Topic 4 Treating HCV in Persons with Decompensated Cirrhosis

5Topic 5 Summary Points

Lesson Quiz Treatment of HCV in Persons with Cirrhosis Quiz

Survey Lesson Survey

Quick Reference View

A single document for easy access to every topic in the self-study modules.

PDF version also available.

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.